Form Type: 4

Accession Number:	0001209191-22-038386
Date:	2022-06-16
Issuer:	ARCUS BIOSCIENCES, INC. (RCUS)
Original Submission Date:

Reporting Person:

JAEN JUAN C.
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY HAYWARD, CA 94545

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of Security	Transaction Date	2a. Deemed Execution Date	Transaction Code	Shares	Acquired or Disposed	Price per share	5. Amount of Securities Beneficially Owned Following Reported Transaction	6. Ownership Form Direct or Indirect	Nature of Indirect Ownership
COMMON STOCK	2022-06-16		S	2,333	d	$20.72	212,574	direct
COMMON STOCK	2022-06-17		S	748	d	$21.71	211,826	direct
COMMON STOCK	2022-06-17		S	1,789	d	$22.29	210,037	direct
COMMON STOCK	2022-06-16			0		$0.00	1,222,240	indirect

Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security	Conversion or Exercise Price of Derivative Security	Transaction Date	Deemed Execution Date	Transaction Code	Number of Derivative Securities Acquired (A) or Disposed of (D)	Date Exercisable	Expiration Date	Title and Amount of Securities Underlying Derivative Security	Price of Derivative Security	Number of derivative Securities Beneficially Owned Following Reported Transaction(s)	Ownership Form: Direct (D) or Indirect (I)	Nature of Indirect Beneficial Ownership

Footnotes
ID	footnote
f1	represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain rsus, previously reported in table i following the date of grant. the sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
f2	the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $20.33 to $21.16, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f3	the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $21.14 to $22.12, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f4	the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $22.14 to $22.53, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Elevate your investments